Mira L. Katz, Laura E. Archer, Jeffrey M. Peppercorn, Sandra Kereakoglow, Deborah E. Collyar, Harold J. Burstein, Richard L. Schilsky and Ann H. Partridge Patient advocates' role in clinical trials Cancer 118
Version of Record online: 5 MAR 2012 | DOI: 10.1002/cncr.27485
The majority of Cancer and Leukemia Group B (CALGB) patient advocates and investigators perceive benefits from patient advocate involvement in the clinical trials process. Strategies to improve advocate-investigator communication to enhance the role of patient advocates in the clinical trial process are warranted.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field